Together for better?
- PMID: 26823507
- DOI: 10.1182/blood-2015-11-678524
Together for better?
Abstract
In this issue of Blood, Mateos et al report that bortezomib plus melphalan and prednisone (VMP) and lenalidomide plus low-dose dexamethasone (Rd) administered in a sequential or an alternating scheme were equally active and induced comparable toxicities in elderly myeloma patients.
Comment on
-
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM.Blood. 2016 Jan 28;127(4):420-5. doi: 10.1182/blood-2015-08-666537. Epub 2015 Oct 23. Blood. 2016. PMID: 26500339 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous

